Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.
Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define ESDN function in primary human VSMCs. ESDN down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased ERK1/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFRbeta expression levels. In binding assays, ESDN down-regulation significantly increased (125)I-PDGF maximum binding (B(max)) to PDGF receptors on VSMCs without altering the binding constant (K(d)), raising the possibility that ESDN regulates PDGFR processing. ESDN down-regulation significantly reduced ligand-induced PDGFRbeta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFRbeta. Thus, ESDN modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The ESDN effect is mediated, at least in part, through effects on PDGFRbeta ubiquitination. ESDN may serve as a target for regulating PDGFRbeta signaling in VSMCs.
Guo
Xiaojia
X
Cardiovascular Molecular Imaging Laboratory, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Nie
Lei
L
Esmailzadeh
Leila
L
Zhang
Jiasheng
J
Bender
Jeffrey R
JR
Sadeghi
Mehran M
MM
D002478:Cells, Cultured; D015536:Down-Regulation / Q000502:physiology*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D032389:Myocytes, Smooth Muscle / Q000378:metabolism*; D010766:Phosphorylation / Q000502:physiology; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D050721:Proto-Oncogene Proteins c-cbl / Q000378:metabolism; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism; D054875:Ubiquitination / Q000502:physiology; D019061:src-Family Kinases / Q000378:metabolism
C436326:DCBLD2 protein, human; D008565:Membrane Proteins; D010982:Platelet-Derived Growth Factor; D050721:Proto-Oncogene Proteins c-cbl; D044767:Ubiquitin-Protein Ligases; D020797:Receptor, Platelet-Derived Growth Factor beta; D019061:src-Family Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; C067419:CBL protein, human
Arterioscler Thromb. 1993 Aug;13(8):1218-26
8343497
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):795-801
12637337
J Biol Chem. 1993 Jan 5;268(1):577-83
8380168
Platelets. 2001 Sep;12(6):352-8
11672474
Science. 1999 Oct 8;286(5438):309-12
10514377
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2946-51
15710889
Am J Physiol Cell Physiol. 2007 Jan;292(1):C59-69
16956962
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2597-605
17951322
J Biol Chem. 1993 Oct 15;268(29):21478-81
7691811
J Biol Chem. 2007 Dec 28;282(52):37815-25
17971444
J Biol Chem. 1999 Jun 4;274(23):16619-28
10347229
Circ Res. 2007 Sep 28;101(7):672-81
17704212
J Biol Chem. 2007 Oct 5;282(40):29336-47
17620338
Curr Opin Cell Biol. 1995 Apr;7(2):176-82
7612268
Biochem Soc Trans. 2004 Jun;32(Pt3):443-6
15157156
J Biol Chem. 2001 Sep 7;276(36):34105-14
11447234
J Cell Biol. 1996 Feb;132(4):741-52
8647902
Physiol Rev. 2004 Jul;84(3):767-801
15269336
Cell Signal. 2006 Jul;18(7):971-81
16214305
Mol Cell Biol. 2004 Mar;24(5):2190-201
14966296
Circ Res. 2004 May 14;94(9):1219-26
15059930
Am J Physiol Cell Physiol. 2007 Feb;292(2):C886-95
16987998
Am J Transplant. 2007 Sep;7(9):2098-105
17697260
J Biol Chem. 1995 Dec 8;270(49):29447-52
7493983
J Cell Physiol. 2006 Oct;209(1):21-43
16741904
Surgery. 1997 Aug;122(2):138-44; discussion 144-5
9288116
Oncogene. 2002 Apr 25;21(18):2822-8
11973641
J Biol Chem. 1992 Mar 25;267(9):6429-34
1313434
Mol Cancer Res. 2008 Feb;6(2):222-30
18314483
EMBO J. 1997 Sep 15;16(18):5600-7
9312019
Genes Dev. 2008 May 15;22(10):1276-312
18483217